cording to existing research, the current status of treatment of type 2 diabetes in China is not optimistic. 5, 6 Hence, we need more multicenter and large-scale research to investigate the status and goals of diabetes treatment. Therefore, we can provide decisionmaking advice and guidelines to help us reduce diabetes morbidity and mortality. 
| MATERIAL S AND ME THODS

| Patient selection
| Data collection
The investigators were well trained to complete the questionnaire, which included demographic data, the duration of diabetes, patient education, general characteristics (consisting of height, weight, and blood pressure), associated diseases, chronic complications, laboratory indexes in nearly three months (consisting of the glycosylated hemoglobin level, blood lipid, blood glucose, and urinary albumincreatinine ratio), the results of carotid ultrasonography and ophthalmologic examination, and their medication usage. The data of demographics, the duration of diabetes, and the diabetes education were gathered via a face-to-face questionnaire. The height and weight were measured without shoes and coat. The subjects rested at least five minutes before having their blood pressure taken. The associated diseases mainly included hypertension and hyperlipidemia. They could only be confirmed if they had previously had a clear diagnosis. The data source of the blood tests was the laboratory system of each hospital. When there were no records for nearly three months, they were considered "unrecorded." The complications of diabetes were judged by the diagnosis history and medical records. The patients were assumed to have coronary heart disease (CHD) if they had been diagnosed by a cardiologist, and the diagnostic examinations included coronary angiography and coronary artery computed tomography. A stroke was assumed only when the CT or MRI of patients had the corresponding signs. They were treated as negative if they had no records of CHD and a stroke. Retinopathy, arterial plaque, and nephropathy were analyzed based on the abnormality of test results. Retinopathy and arterial plaque were assumed according to the diagnosis of the ophthalmologic test and carotid ultrasonography. We treated them as "unmeasured" if they had no history of testing or diagnosis. Their hypotensor and antidiabetic medication use history was acquired by their previous medical advice and the responses of patients.
| Reference standard
The standard of the study was 2013 China guideline for T2DM.
The target values were set as follows: fasting blood glucose (FBG) 4. Diabetic nephropathy was defined as glomerular filtration rate (GFR) <60 mL/min/1.73m 2 or urinary albumin-creatinine ratio >30 mg/g for more than 3 months . 10 The estimated glomerular filtration rate was calculated by improved Chinese population MDRD formula. 
| Definitions
| RE SULTS
| General characteristics of the subjects
| Associated diseases and chronic complications
In the 3015 subjects, 58.7% had hypertension; the prevalence of hypertension was higher in women (60.2%) than in men (57.4%), but it was not statistically significant. 56.7% suffered from dyslipidemia, with statistical significance between men and women. Women had a higher proportion (60.2% compared with 53.9% in men). The examination rate of carotid ultrasonography, urinary albumin-creatinine ratio, and an ophthalmologic test among all subjects was 40.5%, 51.0%, and 9.1%, respectively. In the examinees, retinopathy was present in 14.5%. The percentage of women who had retinopathy (19.7%) was higher than that of men (10.1%). The prevalence of nephropathy was 11.6% overall, and the percentage of women who had nephropathy (13.5%) was higher than that of men (10.0%). Regarding arterial plaque, the prevalence among all subjects was 53.1%, and men had a higher ratio (56.4%) than women (49.3%). Retinopathy, nephropathy, and arterial plaque all had statistically significant gender differences. The proportion of known patients with coronary heart disease and stroke was 1.9% and 1.6%, respectively. The incidence of cardiovascular disease in women was higher than that in men, while the prevalence of cerebrovascular diseases was approximately the same among men and women (Table 1 ,2).
| Level of metabolism and target achievement rate
The average SBP and DBP among all subjects were 135.8 and The percentage of subjects with a BMI<24.0 kg/m 2 was 49.1%. The achievement rate of women (52.0%) was higher than that of men (46.8%); 2747 patients had available records for blood pressure, blood glucose, and LDL-C simultaneously. Of these subjects, 354
(12.9%) reached all three treatment targets, of which men (13.8%) were higher than women (11.7%). (Figure 1 , Tables 3 and 4) .
| Diabetes treatment
Among the 3015 subjects, information from 2651 patients was avail- used an oral agent and insulin for diabetes treatment. (Figure 2 ).
| D ISCUSS I ON
The treatment status of 3015 patients with type 2 diabetes in nine hospitals of different grades, such as tertiary general hospital, secondary general hospital, and basic hospital, was investigated.
The control of blood pressure, glycemia, and LDL-C is absolutely crucial to the prevention of diabetes complications. The LDL-C, mmol/L (n = 2747) 2.6 ± 0.9 2.5 ± 0.9 2.7 ± 0.8 <0.01 DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; RBG, random blood glucose; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride. In our study, the prevalence of dyslipidemia was 56.7% and the rate of controlling LDL-C to <2.6 mmol/L (equal to 100 mg/dL; and <1.8 mmol/L if accompanied by CHD, equal to 70 mg/dL) was 51.7%. The achievement rate of LDL-C is higher than 45.1% of patients whose LDL-C was less than 100 mg/dL reported by a nationwide multi-center study of China in 2010 16 and higher than 45.5%
TA B L E 3 Clinical and disease-related characteristics
of patients who reached the LDL-C goal (<100 mg/dL) reported by Iran, 14 and 25%-50% reported by multiple domestic studies in Korea, [22] [23] [24] but lower than 55.7% reported by the Taiwanese Association of Diabetes Educators in 2006-2011%, 17 and 56.2%
patients met the goal of LDL-C < 100 mg/dL in 2007-2010 in the United States, 21 moreover, another study in America reported that 82.0% of patients achieved the goal in a community-based endocrinology practice. 25 The average BMI was 24.2 ± 3.4 kg/ m 2% , and 49.1% achieved a reduction in BMI to <24 kg/m 2 , which is lower than that in Korea 26 and Western countries. 20, 27 According to the comparison, the control of four metabolic indexes-blood pressure, blood glucose, blood lipid, and body mass index-was remarkably improved compared with the results in 2010, and better than that in some Asian and European countries, but there was still a gap compared with developed countries such as the United States.
The prevalence of retinopathy was 14.5%, which is lower than the average prevalence of 21% in Asia. 28 The prevalence of nephropathy was 11.6%, which is lower than the 20%-30% reported in Korea 23, 24 and the average in Asian countries. 28 However, the prevalence is higher than in Eastern Europe. 29 The proportion of patients known to have coronary heart disease and cerebrovascular disease was 1.9% and 1.6%, respectively, which were lower than the average in Asian countries. 28 There is an absence of existing studies reporting the prevalence of diabetes complications. We believe that the difference in the prevalence between countries is partly due to the different diagnosis methods and the examination rates. The prevalence of arterial plaque was 53.1% in our study; we are unable to compare this to other studies because of the lack of domestic or international reports, but it can be considered a reference for controlling improvements in the future.
Regarding diabetes treatment, 4.2% of patients chose exercise and diet control to reduce their blood glucose, 73.1% of patients only used an oral agent (a significant increase compared to 34.74% of patients in 2010), and 4.4% of patients only used insulin (a significant decrease from 23.47% of patients in 2010). In addition, 18.4% of patients combined the usage of an oral agent and insulin for diabetes treatment, and 22.8% of patients received insulin with or without an oral agent, similar to the average 24% of patients in Asia and 15% to 25% of patients in Europe, but lower than the 30% of patients in the United States. In addition, 91.5% of patients received an oral agent with or without insulin, which was higher than the average 80% of patients in Asia countries. 10, [28] [29] [30] However, our research also has its limitations. We only investigated nine hospitals in Ningbo, which did not reflect the general management of type 2 diabetes in China. Therefore, a larger national study is needed.
In conclusion, the study showed that the treatment status of type 2 diabetes had a marked improvement compared with six years ago, but there is still a gap between the developed countries like the United States and the 2013 China guideline for T2DM. Therefore, there is an urgent need for more active diabetes management.
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